Y Ozisik
Overview
Explore the profile of Y Ozisik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zengin N, Kars A, Kansu E, Ozdemir O, Barista I, Gullu I, et al.
Hematology
. 2016 Jul;
2(2):125-9.
PMID: 27406802
Staging systems are essential for understanding disease, in predicting the outcome, and therapeutic decision making in any tumor as well as chronic lymphocytic leukemia (CLL). In this study, we compared...
2.
Dede D, Gumuskaya B, Guler G, Onat D, Altundag K, Ozisik Y
J BUON
. 2013 Jul;
18(2):366-71.
PMID: 23818347
Purpose: The aim of this study was to assess the changes in biologic markers of breast cancer ER, PR, HER 2 and Ki-67 in locally advanced breast cancer patients after...
3.
Turkoz F, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, et al.
J BUON
. 2013 Jul;
18(2):335-41.
PMID: 23818343
Purpose: The increasing incidence of obesity throughout the world will result in expansion of the number of women at risk for developing breast cancer. Obesity is associated with adverse outcomes...
4.
Dede D, Gumuskaya B, Guler G, Onat D, Altundag K, Ozisik Y
J BUON
. 2013 Apr;
18(1):57-63.
PMID: 23613389
Purpose: To assess the changes of biologic markers estrogen receptors (ER), progesterone receptors (PR), HER 2 and Ki-67 in locally advanced breast cancer patients after neoadjuvant chemotherapy. Methods: Data from...
5.
Petekkaya I, Akin T, Gezgen G, Roach E, Ozisik Y, Altundag K
J BUON
. 2013 Jan;
17(4):800.
PMID: 23335549
No abstract available.
6.
Turkoz F, Solak M, Aksoy S, Petekkaya I, Keskin O, Kertmen N, et al.
J BUON
. 2013 Jan;
17(4):649-57.
PMID: 23335520
Purpose: To evaluate the clinicopathologic characteristics and survival of patients with family history of breast/ ovarian cancer (FHBOC). Methods: In this study with 1987 breast cancer patients, we analyzed their...
7.
Arslan C, Ozdemir E, Dogan E, Ozisik Y, Altundag K
J BUON
. 2012 Feb;
16(4):744-50.
PMID: 22331732
Purpose: To determine the frequency of secondary hematological malignancies in non-metastatic breast cancer (BC) patients who received adjuvant chemotherapy and radiotherapy. Methods: Data of BC patients followed at Hacettepe University...
8.
Dogan E, Aksoy S, Dizdar O, Arslan C, Dede D, Ozisik Y, et al.
J BUON
. 2011 Oct;
16(3):565-7.
PMID: 22006768
Purpose: Mucinous breast carcinoma is rare subtype of breast cancer. Histopathologically, it is classified into two forms, pure and mixed type. It recurs late, metastasis to axillary lymph nodes is...
9.
Ararat E, Sahin I, Arslan C, Aksoy S, Dizdar O, Ozisik Y, et al.
J BUON
. 2011 Jul;
16(2):372.
PMID: 21766514
No abstract available.
10.
Ozisik Y, Meloni A, Sandberg A
Int J Oncol
. 2011 May;
1(5):533-7.
PMID: 21584576
Chromosomal abnormalities can be applied in the diagnosis and classification of some metastases of unknown origin. A selective search is most appropriate for treatable tumors, such as prostate, ovary, breast,...